<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Geriatrics (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Geriatrics (Basel)</journal-id><journal-id journal-id-type="publisher-id">geriatrics</journal-id><journal-title-group><journal-title>Geriatrics</journal-title></journal-title-group><issn pub-type="epub">2308-3417</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407572</article-id><article-id pub-id-type="pmc">PMC12101355</article-id>
<article-id pub-id-type="doi">10.3390/geriatrics10030065</article-id><article-id pub-id-type="publisher-id">geriatrics-10-00065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>A Systematic Review on Subjective Cognitive Complaints: Main Neurocognitive Domains, Myriad Assessment Tools, and New Approaches for Early Detection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Webster-Cordero</surname><given-names>Felipe</given-names></name><xref rid="af1-geriatrics-10-00065" ref-type="aff">1</xref><xref rid="af2-geriatrics-10-00065" ref-type="aff">2</xref><xref rid="c1-geriatrics-10-00065" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4091-489X</contrib-id><name><surname>Gim&#x000e9;nez-Llort</surname><given-names>Lydia</given-names></name><xref rid="af1-geriatrics-10-00065" ref-type="aff">1</xref><xref rid="af3-geriatrics-10-00065" ref-type="aff">3</xref><xref rid="c1-geriatrics-10-00065" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Tappen</surname><given-names>Ruth Marchand</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Rosselli</surname><given-names>M&#x000f3;nica</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-geriatrics-10-00065"><label>1</label>Department of Psychiatry and Forensic Medicine, School of Medicine, Universitat Aut&#x000f2;noma de Barcelona, E-08193 Barcelona, Spain</aff><aff id="af2-geriatrics-10-00065"><label>2</label>Hospital Santa In&#x000e9;s, Neuropsychology Service, Av. Daniel C&#x000f3;rdova T, 2-67 y Agust&#x000ed;n Cueva, Cuenca 010107, Ecuador</aff><aff id="af3-geriatrics-10-00065"><label>3</label>Institut de Neuroci&#x000e8;ncies, Universitat Aut&#x000f2;noma de Barcelona, E-08193 Barcelona, Spain</aff><author-notes><corresp id="c1-geriatrics-10-00065"><label>*</label>Correspondence: <email>felipeedmundo.webster@autonoma.cat</email> or <email>felipe.webster@ucuenca.edu.ec</email> (F.W.-C.); <email>lidia.gimenez@uab.cat</email> (L.G.-L.); Tel.: +593-984884724 (F.W.-C.); +34-935812378 (L.G.-L.)</corresp></author-notes><pub-date pub-type="epub"><day>09</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>10</volume><issue>3</issue><elocation-id>65</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>24</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background/Objectives:</bold> Neuropsychological testing is key in defining cognitive profiles at early stages of dementia. More importantly, the detection of subtle cognitive changes, such as subjective cognitive complaints (SCCs), an understudied phenomenon, is critical for early detection and preventive interventions. <bold>Methods:</bold> This systematic review analyzes the empirical data on the cognitive domains and neuropsychological tests used in studies addressing SCC in the last 15 years (2009&#x02013;2024). <bold>Results:</bold> A selection of 15 papers with exploratory, cross-sectional, and prospective scope in this field was obtained from PubMed and Embase databases. They used screening tests (17%) and a broad spectrum of neurocognitive domains. Yet, we identified three main targeted cognitive domains: executive functions (28%), language (17%), and memory (17%). Myriad assessment tools were also applied, but the most commonly used was a set of eight tests: Mini-mental Scale Examination (MMSE), Trail Making Test (A-B), Stroop test, Digit span test (DST), Semantic and Phonological fluency test, Rey Auditory Verbal Learning Test (RAVLT), Weschler Memory Scale (WMS), and Boston Naming Test (BNT). New approaches involved including the Geriatric Depression Scale (GDS) and self/informant reports. <bold>Conclusions:</bold> Despite scarce agreement in the assessment protocols, the identification of early neurocognitive symptoms to objectivate the SCC phenomenon envisions a broad field of research.</p></abstract><kwd-group><kwd>subjective cognitive complaints</kwd><kwd>dementia</kwd><kwd>neuropsychological assessment</kwd><kwd>neuropsychological test</kwd></kwd-group><funding-group><funding-statement>The present work was performed without funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-geriatrics-10-00065"><title>1. Introduction</title><p>To date, there has been an increase in the number of people attending neurological and/or neuropsychological consultations due to the presence of subjective cognitive complaints (SCCs). Although this or similar terms, such as subjective cognitive decline (SCD), are not included in international diagnostic manuals ICD-11 or DSM-5, SCC has gained significant relevance over the past decade to describe a condition characterized by a persistent self-perception of reduced cognitive performance beyond what is typical, without objective evidence, following standardized clinical assessment [<xref rid="B1-geriatrics-10-00065" ref-type="bibr">1</xref>]. Its importance in the clinical field lies in its potential relationship to subsequent progression to disorders such as mild cognitive impairment (MCI) and dementia [<xref rid="B1-geriatrics-10-00065" ref-type="bibr">1</xref>,<xref rid="B2-geriatrics-10-00065" ref-type="bibr">2</xref>,<xref rid="B3-geriatrics-10-00065" ref-type="bibr">3</xref>]. Thus, it is estimated that within one year, SCC may progress to MCI in 6.6% of cases and to dementia in 2.3%; over four years, this progression increases to 24.4% for MCI and 10.9% for dementia [<xref rid="B4-geriatrics-10-00065" ref-type="bibr">4</xref>]. Consequently, research on this phenomenon and its potential relationship with the preclinical onset of certain neurodegenerative diseases has grown in the last decade.</p><p>Clinical neuropsychology has provided a broad perspective on cognitive changes associated with various neurological conditions to facilitate their diagnosis, serving as a screening before biological markers or other tests can be applied. In the dementia continuum, neurocognitive evaluation has been incorporated into the protocols of multidisciplinary teams worldwide, from preclinical and prodromal to advanced stages [<xref rid="B5-geriatrics-10-00065" ref-type="bibr">5</xref>,<xref rid="B6-geriatrics-10-00065" ref-type="bibr">6</xref>]. Based on clinical judgment and the analysis by complementary laboratory and neuroimaging tests, the professional team determines a final diagnosis to implement specific treatments that can be also monitored [<xref rid="B7-geriatrics-10-00065" ref-type="bibr">7</xref>]. Consequently, neuropsychological assessment has become indispensable in clinical evaluations because of its contribution to identifying existing cognitive deficits to support differential diagnoses, clinical management, and forensic utility [<xref rid="B5-geriatrics-10-00065" ref-type="bibr">5</xref>,<xref rid="B6-geriatrics-10-00065" ref-type="bibr">6</xref>]. In this context, specific neuropsychological assessment for patients with cognitive complaints and suspected neurodegenerative diseases should also complement routine medical studies [<xref rid="B8-geriatrics-10-00065" ref-type="bibr">8</xref>]. However, as shown by clinical studies addressing early detection of subtle cognitive changes, many neuropsychological tests are used, ranging from screening tests to domain-specific tests. Most importantly, there is no consensus on the types of tests to be applied in clinical evaluations, with the choice of tests varying depending on the study [<xref rid="B9-geriatrics-10-00065" ref-type="bibr">9</xref>]. Since SCC remains a poorly explored phenomenon, yet is critical for early detection and preventive interventions, this review aims to systematically analyze the empirical data on the neuropsychological tests used in the different studies addressing subjective cognitive impairments.</p></sec><sec sec-type="methods" id="sec2-geriatrics-10-00065"><title>2. Methodology</title><p>The objective of this review is to systematically analyze empirical data on neuropsychological tests used in various studies addressing the topic of SCC. This systematic review was registered at the PROSPERO 2025 CRD420251029323. PRISMA method guidelines [<xref rid="B10-geriatrics-10-00065" ref-type="bibr">10</xref>] were used to ensure its proper execution (<xref rid="geriatrics-10-00065-f001" ref-type="fig">Figure 1</xref>). </p><sec id="sec2dot1-geriatrics-10-00065"><title>2.1. Systematic Search (Databases, Descriptors, Search Formulas)</title><p>Since the number of scientific publications interested in SCC increased at the end of the first decade of this millennium, the studies of the last 15 years (2009&#x02013;2024) on the selected topic were analyzed using the PubMed and Embase databases as the primary tools. The terms &#x0201c;neuropsychological evaluation&#x0201d;, &#x0201c;cognitive assessment&#x0201d;, &#x0201c;neuropsychological assessment&#x0201d;, &#x0201c;subjective cognitive decline&#x0201d;, and &#x0201c;subjective cognitive complaints&#x0201d; used in the search with the Booleans &#x0201c;AND&#x0201d; and &#x0201c;OR&#x0201d; yielded 518 results as potential sources for analysis. Inclusion and exclusion criteria were then established. </p></sec><sec id="sec2dot2-geriatrics-10-00065"><title>2.2. Inclusion Criteria</title><list list-type="simple"><list-item><label>-</label><p>Empirical research on neuropsychological tools used in the study of subjective cognitive complaints.</p></list-item><list-item><label>-</label><p>Studies published in the last 15 years with a population aged 60 or older with subjective cognitive complaints.</p></list-item></list></sec><sec id="sec2dot3-geriatrics-10-00065"><title>2.3. Exclusion Criteria</title><list list-type="simple"><list-item><label>-</label><p>Studies addressing neuropsychological tests for subjective cognitive complaints in other clinical contexts (pathologies or neurologic/psychiatric diseases that may also involve SCC).</p></list-item><list-item><label>-</label><p>Research exploring neuropsychological assessments in mild cognitive impairment and advanced stages of dementia.</p></list-item></list></sec><sec id="sec2dot4-geriatrics-10-00065"><title>2.4. Flow Chart</title><p>Following these criteria, 73 studies were initially selected based on their titles. After reviewing their abstracts, 58 studies were excluded because they did not meet the specific objective of this review. Finally, 15 articles were selected for review because they focused on the study of cognitive performance in individuals with subjective cognitive complaints. </p></sec></sec><sec sec-type="results" id="sec3-geriatrics-10-00065"><title>3. Results</title><sec id="sec3dot1-geriatrics-10-00065"><title>3.1. Most Relevant Data from the Studies Included in This Review</title><p><xref rid="geriatrics-10-00065-t001" ref-type="table">Table 1</xref> highlights a summary of the most relevant data from the 15 selected clinical studies. The studies used longitudinal, follow-up experimental, and cross-sectional descriptive designs. All studies included neuropsychological assessments as a critical component in analyzing the clinical profiles of their participants.</p></sec><sec sec-type="subjects" id="sec3dot2-geriatrics-10-00065"><title>3.2. Participants and Sociodemographic Variables</title><p>Analyzing the overall data, a total sample of 589,008 participants is included from Western countries (Australia, Central and Southern Europe, North and South America) and Eastern countries (Korea and China). Sociodemographic variables include gender (with a women: men ratio of 3:1), age (average 65.4 years), and years of education (average 9.9 years).</p></sec><sec id="sec3dot3-geriatrics-10-00065"><title>3.3. Neuropsychological Domains</title><p>Despite the significant heterogeneity in the methodology used in each study and the complexity of clinical assessment in these preclinical phases, current studies on SCC are aligned to consider it as a clinical entity with its characteristics that can be objectified through formal assessment protocols and be a stage prior to MCI and dementia [<xref rid="B4-geriatrics-10-00065" ref-type="bibr">4</xref>,<xref rid="B26-geriatrics-10-00065" ref-type="bibr">26</xref>].</p><p>Different cognitive and behavioral domains were assessed using various neuropsychological tools. As illustrated in <xref rid="geriatrics-10-00065-f002" ref-type="fig">Figure 2</xref>, a significant number of studies applied tests for executive functions (28%), screening tests (17%), and tests to assess language and memory processes (17%). Other cognitive domains were assessed to a lesser extent (depression/anxiety&#x02014;6%, self-reports/report informants&#x02014;5%, visuospatial processes&#x02014;4%, praxis&#x02014;3%, visual perceptual processes&#x02014;2%, intelligence&#x02014;1%).</p></sec><sec id="sec3dot4-geriatrics-10-00065"><title>3.4. Neuropsychological Tests</title><p>On the other hand, the most commonly used neuropsychological tests in the different studies were the MMSE as the main screening test (77%), the TMT A-B, Stroop test and the DST for executive performance (62%, 38% and 38% respectively), Semantic and Phonological fluency tests and the BNT for language (38% and 31% respectively), the RAVLT (31%) and the WMS (23%) as memory tests, and the GDS (22%) for the assessment of anxiety and depression symptoms (<xref rid="geriatrics-10-00065-t002" ref-type="table">Table 2</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-geriatrics-10-00065"><title>4. Discussion</title><p>The preclinical and prodromal stages of dementia are associated with subtle changes in various cognitive processes beyond memory, which were initially linked to neurodegenerative diseases [<xref rid="B5-geriatrics-10-00065" ref-type="bibr">5</xref>]. Employing neuropsychological tests as part of care protocols for patients with early cognitive difficulties has become an essential tool for the early diagnosis of potential neurodegenerative conditions, such as dementia. However, identifying tools sensitive enough to assess neurocognitive processes&#x02014;particularly in a subjective phenomenon like SCC&#x02014;is complex and demands extensive analysis [<xref rid="B1-geriatrics-10-00065" ref-type="bibr">1</xref>,<xref rid="B6-geriatrics-10-00065" ref-type="bibr">6</xref>,<xref rid="B27-geriatrics-10-00065" ref-type="bibr">27</xref>,<xref rid="B28-geriatrics-10-00065" ref-type="bibr">28</xref>].</p><p>In this review, it is found that various authors employed neuropsychological screening tests to assess people with SCC. In some instances, screening was followed by specific tests or scales targeting different cognitive domains, including memory, language, perception, visuospatial function, praxis, and executive function [<xref rid="B11-geriatrics-10-00065" ref-type="bibr">11</xref>,<xref rid="B12-geriatrics-10-00065" ref-type="bibr">12</xref>,<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>,<xref rid="B14-geriatrics-10-00065" ref-type="bibr">14</xref>,<xref rid="B15-geriatrics-10-00065" ref-type="bibr">15</xref>,<xref rid="B16-geriatrics-10-00065" ref-type="bibr">16</xref>,<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>,<xref rid="B18-geriatrics-10-00065" ref-type="bibr">18</xref>,<xref rid="B19-geriatrics-10-00065" ref-type="bibr">19</xref>,<xref rid="B20-geriatrics-10-00065" ref-type="bibr">20</xref>,<xref rid="B21-geriatrics-10-00065" ref-type="bibr">21</xref>,<xref rid="B22-geriatrics-10-00065" ref-type="bibr">22</xref>,<xref rid="B23-geriatrics-10-00065" ref-type="bibr">23</xref>,<xref rid="B24-geriatrics-10-00065" ref-type="bibr">24</xref>,<xref rid="B25-geriatrics-10-00065" ref-type="bibr">25</xref>]. Among the limitations observed are the methodological heterogeneity among studies, the fact that some tools can be used to assess more than one domain, the complexity of clinical assessment during these preclinical phases, along with the lack of agreement on selection criteria. Despite these challenges, current studies on SCC aligned to consider its characteristics can be objectively evaluated through formal assessment protocols, positioning SCC as a potential stage prior to MCI and dementia [<xref rid="B4-geriatrics-10-00065" ref-type="bibr">4</xref>,<xref rid="B26-geriatrics-10-00065" ref-type="bibr">26</xref>].</p><p>The validity of screening tests in identifying preclinical and prodromal signs of dementia is often insufficient. While there are screening tools that may indicate potential issues, they are not definitive. Nonetheless, some studies in this review suggested [<xref rid="B11-geriatrics-10-00065" ref-type="bibr">11</xref>,<xref rid="B12-geriatrics-10-00065" ref-type="bibr">12</xref>,<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>,<xref rid="B14-geriatrics-10-00065" ref-type="bibr">14</xref>,<xref rid="B15-geriatrics-10-00065" ref-type="bibr">15</xref>,<xref rid="B16-geriatrics-10-00065" ref-type="bibr">16</xref>,<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>,<xref rid="B19-geriatrics-10-00065" ref-type="bibr">19</xref>,<xref rid="B20-geriatrics-10-00065" ref-type="bibr">20</xref>,<xref rid="B23-geriatrics-10-00065" ref-type="bibr">23</xref>,<xref rid="B25-geriatrics-10-00065" ref-type="bibr">25</xref>] that the Mini-Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Alzheimer&#x02019;s Disease Assessment Scale&#x02013;Cognitive (ADAS-cog) were primarily used. Some authors believe that the MMSE may be accurate for detecting Alzheimer&#x02019;s disease; however, they recommend using the Montreal Cognitive Assessment (MoCA) for detecting MCI, as it is a more sensitive test for measuring early cognitive changes [<xref rid="B29-geriatrics-10-00065" ref-type="bibr">29</xref>,<xref rid="B30-geriatrics-10-00065" ref-type="bibr">30</xref>].</p><p>In contrast, it has always been argued that tests such as the Mini-Mental State Examination (MMSE), among other screening tools, have not proven to be sufficiently sensitive for assessment in primary care. The authors further discuss that other factors, such as administration time or individual circumstances (educational level, sensory problems, and others), may interfere with applying basic tests, failing to identify specific cognitive issues. Kueper et al. [<xref rid="B31-geriatrics-10-00065" ref-type="bibr">31</xref>], on the other hand, suggest that the ADAS-cog is not an optimal tool for detecting subtle pre-dementia changes and that it should be used in parallel with other tests that more accurately assess memory processes, executive functions, and daily living activities. In fact, in our recent clinical study in an at-risk Sub-Saharan diabetic population, the use of a 6-CTI scale in parallel to MMSE was shown to be more sensitive to unveiling the existence of cognitive deficiencies in the subgroup of the low-educated diabetic female population [<xref rid="B32-geriatrics-10-00065" ref-type="bibr">32</xref>].</p><p>The use of specific neurocognitive tests is essential in clinical assessment. Most studies (11 out of 15) used screening tests, and also most of them (10 out of 15) applied other complementary tests targeting different cognitive domains [<xref rid="B11-geriatrics-10-00065" ref-type="bibr">11</xref>,<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>,<xref rid="B14-geriatrics-10-00065" ref-type="bibr">14</xref>,<xref rid="B16-geriatrics-10-00065" ref-type="bibr">16</xref>,<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>,<xref rid="B18-geriatrics-10-00065" ref-type="bibr">18</xref>,<xref rid="B20-geriatrics-10-00065" ref-type="bibr">20</xref>,<xref rid="B22-geriatrics-10-00065" ref-type="bibr">22</xref>,<xref rid="B23-geriatrics-10-00065" ref-type="bibr">23</xref>,<xref rid="B24-geriatrics-10-00065" ref-type="bibr">24</xref>]. The studies also pointed out the relevance of using specific neurocognitive tests and considering formal informant reports that can provide sufficient information to the clinician to make more accurate diagnosis [<xref rid="B33-geriatrics-10-00065" ref-type="bibr">33</xref>]. However, the assessment of different cognitive domains poses a challenge in determining early cognitive impairment in neurodegenerative diseases. Although the studies included in this review used several specific cognitive tests, there was no consensus on which tests are crucial for implementation and which key cognitive process should be evaluated. Despite this fact, as can be seen, several of the studies on SCC performed an in-depth assessment of mnestic, linguistic, and executive processes. This will be in agreement with measures of delayed recall being considered the best neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer&#x02019;s disease [<xref rid="B34-geriatrics-10-00065" ref-type="bibr">34</xref>,<xref rid="B35-geriatrics-10-00065" ref-type="bibr">35</xref>], as well as certain linguistic components [<xref rid="B36-geriatrics-10-00065" ref-type="bibr">36</xref>,<xref rid="B37-geriatrics-10-00065" ref-type="bibr">37</xref>]. On the other hand, the literature also suggests that the assessment of executive functions such as working memory, attentional control, planning, and others could be a critical factor in the identification of possible pathological signs in the preclinical stages of dementia [<xref rid="B38-geriatrics-10-00065" ref-type="bibr">38</xref>,<xref rid="B39-geriatrics-10-00065" ref-type="bibr">39</xref>].</p><p>The terminology used to refer to subjective complaints of patients in studies determining their possible relationship with MCI and dementia is heterogeneous. This can be probably considered the main limitation in this field. Subjective cognitive complaints are still a phenomenon, a &#x0201c;non-clinical&#x0201d; entity for which different terms such as &#x0201c;subjective cognitive complaints&#x0201d;, &#x0201c;subjective cognitive decline&#x0201d;, &#x0201c;subtle cognitive impairment&#x0201d;, &#x0201c;pre-MCI&#x0201d;, or &#x0201c;pre-AD&#x0201d; are used. Their equivalence corresponds to the fact that all studies define this phenomenon as the preclinical stage of various conditions that can transform into MCI or dementia. To solve this issue, in the present review, the verbatim from each study has been taken. For instance, in Valech&#x02019;s study [<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>], the term &#x0201c;pre-AD&#x0201d; refers to a preclinical stage of Alzheimer&#x02019;s disease, where there is no objective cognitive impairment. In this particular study, in addition to identifying amyloid &#x003b2; (A&#x003b2;) in these stages, the authors determined that subjects may already show subjective decline. They administered a cognitive complaints questionnaire to patients and their families so they could determine the importance of studying subjective complaints at the executive and linguistic levels in the preclinical stages of Alzheimer&#x02019;s disease.</p><p>When referring to the new approaches, it is interesting to note that a small number of studies (4 out of 15) included scales to assess emotional symptoms (depression or anxiety) [<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>,<xref rid="B14-geriatrics-10-00065" ref-type="bibr">14</xref>,<xref rid="B16-geriatrics-10-00065" ref-type="bibr">16</xref>,<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>]. Assessing the emotional domain in older adults with cognitive complaints is crucial; the presence of depressive and anxious symptoms in patients with subjective cognitive complaints is of clinical interest because of their potential association with cognitive impairment and progression to neurodegenerative diseases. The coexistence of depression and/or anxiety with subjective cognitive decline is associated with an increased risk of developing dementia [<xref rid="B2-geriatrics-10-00065" ref-type="bibr">2</xref>,<xref rid="B39-geriatrics-10-00065" ref-type="bibr">39</xref>,<xref rid="B40-geriatrics-10-00065" ref-type="bibr">40</xref>,<xref rid="B41-geriatrics-10-00065" ref-type="bibr">41</xref>]. Therefore, early identification of these symptoms is a crucial component in understanding the subtle emotional changes that may also precede this disease.</p><p>In addition, the use of self-report scales and informant reports seemed to complement the clinical assessment significantly. Some of the reviewed studies used this tool in their studies [<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>,<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>,<xref rid="B20-geriatrics-10-00065" ref-type="bibr">20</xref>,<xref rid="B21-geriatrics-10-00065" ref-type="bibr">21</xref>,<xref rid="B23-geriatrics-10-00065" ref-type="bibr">23</xref>]. The literature indicates that incorporating these tools into cognitive impairment evaluations is essential, as they provide valuable insights into how daily activities may be perceived by individuals and/or their informants [<xref rid="B42-geriatrics-10-00065" ref-type="bibr">42</xref>,<xref rid="B43-geriatrics-10-00065" ref-type="bibr">43</xref>,<xref rid="B44-geriatrics-10-00065" ref-type="bibr">44</xref>].</p><p>Interestingly, behavioral and personality changes do not seem to be of interest in the reviewed studies on SCC. This idea differs from other authors who argue that behavioral changes may be an early signal during the transitional phases between mild cognitive impairment and certain forms of dementia, such as Alzheimer&#x02019;s disease [<xref rid="B45-geriatrics-10-00065" ref-type="bibr">45</xref>,<xref rid="B46-geriatrics-10-00065" ref-type="bibr">46</xref>].</p><p>At last, the limited number of studies and the lack of detailed information about the cultural and educational backgrounds of the participants contribute to heterogeneity and pose significant methodological limitations. Most tests have been designed for Western populations, making the linguistic, educational, and literacy levels of participants crucial for their applicability. Currently, in addition to the existing population, the number of individuals with cognitive impairments from non-Western backgrounds, particularly in lower-middle-income economies, has increased. This trend underscores the need for a methodology that is more valid for individuals with lower educational levels and that allows for the cross-cultural applicability of the instruments used [<xref rid="B32-geriatrics-10-00065" ref-type="bibr">32</xref>,<xref rid="B47-geriatrics-10-00065" ref-type="bibr">47</xref>,<xref rid="B48-geriatrics-10-00065" ref-type="bibr">48</xref>].</p><p>Overall, the various studies reviewed here exhibit significant complexity and heterogeneity when analyzing cognitive performance in patients with SCC. This highlights the urgent need for more evidence regarding the tools to be used in such early stages of cognitive impairment, understanding their reliability and validity, and the multiple variables that may interfere with the results of a standardized and formal evaluation [<xref rid="B49-geriatrics-10-00065" ref-type="bibr">49</xref>]. In addition, studies should accurately determine the characteristics of the SCC phenomenon and emphasize qualitative rather than quantitative analysis of the neuropsychological tests applied, so that preventive/therapeutic intervention protocols may be useful for early care of these conditions [<xref rid="B50-geriatrics-10-00065" ref-type="bibr">50</xref>].</p></sec><sec sec-type="conclusions" id="sec5-geriatrics-10-00065"><title>5. Conclusions and Future Directions</title><p>Clinical attention to subjective cognitive complaints and the tools used to objectify them through the application of a precise neuropsychological evaluation remains challenging for mental health professionals. The heterogeneity of individual characteristics has hindered the availability of tools sensitive enough to detect the initial, often subtle, changes in cognitive performance during the preclinical stages of cognitive decline in older adults. On the other hand, the lack of homogeneity in the protocols used highlights the still uncertain path of clinical tools to unveil the possible subtle changes that occur in preclinical stages of neurodegenerative conditions and to which patients&#x02019; complaints refer.</p><p>The present review identifies that the different studies on SCC agree on the need to perform a screening and specific assessment of cognitive domains, targeting the executive, linguistic, and mnemic components. When analyzing the methodology, there was no agreement on the neurocognitive tests that should be applied to this clinical population with subjective complaints. Yet, the quantitative analysis of their representation in the different studies can give an estimation of clinical common criteria (cognitive domains to be addressed) and the most used tests to do so. Thus, the summary table identifies a set of &#x0201c;most used&#x0201d; tests for these three domains. According to the most recent works, any evaluation protocol should also be complemented with scales or questionnaires that assess emotional aspects and personality. There is sufficient evidence showing that some neurodegenerative conditions can be characterized by behavioral and mood changes, sometimes isolated from cognitive issues, and these may be part of the evolution of the incipient clinical condition. Similarly, formal self-report questionnaires, supplemented by those of informants, can provide valuable information to determine the impact of cognitive complaints on daily activities and provide greater precision when assessing individuals&#x02019; functionality.</p><p>Finally, when addressing the complexity and limitations of neuropsychological assessment in the preclinical stages of dementia, it is essential to conduct studies that accurately unify the criteria for clinical characteristics and possible protocols to be used for the management of subjective cognitive impairment, differentiating them from those applied to mild cognitive impairment. Furthermore, it is crucial not to overlook the complex task of qualitative clinical assessment in any neuropsychological performance study, which should be the subject of future research.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, F.W.-C. and L.G.-L.; methodology, F.W.-C.; writing&#x02014;original draft preparation, F.W.-C.; writing&#x02014;review and editing, F.W.-C. and L.G.-L.; supervision, L.G.-L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-geriatrics-10-00065"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jessen</surname><given-names>F.</given-names></name>
<name><surname>Amariglio</surname><given-names>R.E.</given-names></name>
<name><surname>Buckley</surname><given-names>R.F.</given-names></name>
<name><surname>van der Flier</surname><given-names>W.M.</given-names></name>
<name><surname>Han</surname><given-names>Y.</given-names></name>
<name><surname>Molinuevo</surname><given-names>J.L.</given-names></name>
<name><surname>Rabin</surname><given-names>L.</given-names></name>
<name><surname>Rentz</surname><given-names>D.M.</given-names></name>
<name><surname>Rodriguez-Gomez</surname><given-names>O.</given-names></name>
<name><surname>Saykin</surname><given-names>A.J.</given-names></name>
<etal/>
</person-group><article-title>The characterization of subjective cognitive decline</article-title><source>Lancet Neurol.</source><year>2020</year><volume>19</volume><fpage>271</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(19)30368-0</pub-id><pub-id pub-id-type="pmid">31958406</pub-id>
</element-citation></ref><ref id="B2-geriatrics-10-00065"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liew</surname><given-names>T.M.</given-names></name>
</person-group><article-title>Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia</article-title><source>Alzheimer&#x02019;s Res. Ther.</source><year>2020</year><volume>12</volume><fpage>107</fpage><pub-id pub-id-type="doi">10.1186/s13195-020-00673-8</pub-id><pub-id pub-id-type="pmid">32917264</pub-id>
</element-citation></ref><ref id="B3-geriatrics-10-00065"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jessen</surname><given-names>F.</given-names></name>
</person-group><article-title>Subjective and objective cognitive decline at the pre-dementia stage of Alzheimer&#x02019;s disease</article-title><source>Eur. Arch. Psychiatry Clin. Neurosci.</source><year>2014</year><volume>264</volume><fpage>3</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00406-014-0539-z</pub-id><pub-id pub-id-type="pmid">23942824</pub-id>
</element-citation></ref><ref id="B4-geriatrics-10-00065"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mitchell</surname><given-names>A.J.</given-names></name>
<name><surname>Beaumont</surname><given-names>H.</given-names></name>
<name><surname>Ferguson</surname><given-names>D.</given-names></name>
<name><surname>Yadegarfar</surname><given-names>M.</given-names></name>
<name><surname>Stubbs</surname><given-names>B.</given-names></name>
</person-group><article-title>Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis</article-title><source>Acta Psychiatr. Scand.</source><year>2014</year><volume>130</volume><fpage>439</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1111/acps.12336</pub-id><pub-id pub-id-type="pmid">25219393</pub-id>
</element-citation></ref><ref id="B5-geriatrics-10-00065"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Albert</surname><given-names>M.S.</given-names></name>
<name><surname>Moss</surname><given-names>M.B.</given-names></name>
<name><surname>Tanzi</surname><given-names>R.</given-names></name>
<name><surname>Jones</surname><given-names>K.</given-names></name>
</person-group><article-title>Preclinical prediction of AD using neuropsychological tests</article-title><source>J. Int. Neuropsychol. Soc.</source><year>2001</year><volume>7</volume><fpage>631</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.1017/S1355617701755105</pub-id><pub-id pub-id-type="pmid">11459114</pub-id>
</element-citation></ref><ref id="B6-geriatrics-10-00065"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Begali</surname><given-names>V.L.</given-names></name>
</person-group><article-title>Neuropsychology and the dementia spectrum: Differential diagnosis, clinical management, and forensic utility</article-title><source>NeuroRehabilitation</source><year>2020</year><volume>46</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.3233/NRE-192965</pub-id><pub-id pub-id-type="pmid">32039878</pub-id>
</element-citation></ref><ref id="B7-geriatrics-10-00065"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alzola</surname><given-names>P.</given-names></name>
<name><surname>Carnero</surname><given-names>C.</given-names></name>
<name><surname>Bermejo-Pareja</surname><given-names>F.</given-names></name>
<name><surname>S&#x000e1;nchez-Benavides</surname><given-names>G.</given-names></name>
<name><surname>Pe&#x000f1;a-Casanova</surname><given-names>J.</given-names></name>
<name><surname>Puertas-Mart&#x000ed;n</surname><given-names>V.</given-names></name>
<name><surname>Fern&#x000e1;ndez-Calvo</surname><given-names>B.</given-names></name>
<name><surname>Contador</surname><given-names>I.</given-names></name>
</person-group><article-title>Neuropsychological Assessment for Early Detection and Diagnosis of Dementia: Current Knowledge and New Insights</article-title><source>J. Clin. Med.</source><year>2024</year><volume>13</volume><elocation-id>3442</elocation-id><pub-id pub-id-type="doi">10.3390/jcm13123442</pub-id><pub-id pub-id-type="pmid">38929971</pub-id>
</element-citation></ref><ref id="B8-geriatrics-10-00065"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weintraub</surname><given-names>S.</given-names></name>
</person-group><article-title>Neuropsychological Assessment in Dementia Diagnosis</article-title><source>Continuum</source><year>2022</year><volume>28</volume><fpage>781</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1212/CON.0000000000001135</pub-id><pub-id pub-id-type="pmid">35678402</pub-id>
</element-citation></ref><ref id="B9-geriatrics-10-00065"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Watermeyer</surname><given-names>T.</given-names></name>
<name><surname>Calia</surname><given-names>C.</given-names></name>
</person-group><article-title>Neuropsychological assessment in preclinical and prodromal Alzheimer disease: A global perspective</article-title><source>J. Glob. Health</source><year>2019</year><volume>9</volume><fpage>010317</fpage><pub-id pub-id-type="doi">10.7189/jogh.09.010317</pub-id><pub-id pub-id-type="pmid">31073397</pub-id>
</element-citation></ref><ref id="B10-geriatrics-10-00065"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>n71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id><pub-id pub-id-type="pmid">33782057</pub-id>
</element-citation></ref><ref id="B11-geriatrics-10-00065"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>van Harten</surname><given-names>A.C.</given-names></name>
<name><surname>Smits</surname><given-names>L.L.</given-names></name>
<name><surname>Teunissen</surname><given-names>C.E.</given-names></name>
<name><surname>Visser</surname><given-names>P.J.</given-names></name>
<name><surname>Koene</surname><given-names>T.</given-names></name>
<name><surname>Blankenstein</surname><given-names>M.A.</given-names></name>
<name><surname>Scheltens</surname><given-names>P.</given-names></name>
<name><surname>van der Flier</surname><given-names>W.M.</given-names></name>
</person-group><article-title>Preclinical AD predicts decline in memory and executive functions in subjective complaints</article-title><source>Neurology</source><year>2013</year><volume>81</volume><fpage>1409</fpage><lpage>1416</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a8418b</pub-id><pub-id pub-id-type="pmid">24049134</pub-id>
</element-citation></ref><ref id="B12-geriatrics-10-00065"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toledo</surname><given-names>J.B.</given-names></name>
<name><surname>Bjerke</surname><given-names>M.</given-names></name>
<name><surname>Chen</surname><given-names>K.</given-names></name>
<name><surname>Rozycki</surname><given-names>M.</given-names></name>
<name><surname>Jack</surname><given-names>C.R.</given-names></name>
<name><surname>Weiner</surname><given-names>M.W.</given-names></name>
<name><surname>Arnold</surname><given-names>S.E.</given-names></name>
<name><surname>Reiman</surname><given-names>E.M.</given-names></name>
<name><surname>Davatzikos</surname><given-names>C.</given-names></name>
<name><surname>Shaw</surname><given-names>L.M.</given-names></name>
<etal/>
</person-group><article-title>Memory, executive, and multidomain subtle cognitive impairment</article-title><source>Neurology</source><year>2015</year><volume>85</volume><fpage>144</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001738</pub-id><pub-id pub-id-type="pmid">26085606</pub-id>
</element-citation></ref><ref id="B13-geriatrics-10-00065"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Seo</surname><given-names>E.H.</given-names></name>
<name><surname>Kim</surname><given-names>H.</given-names></name>
<name><surname>Lee</surname><given-names>K.H.</given-names></name>
<name><surname>Choo</surname><given-names>I.H.</given-names></name>
</person-group><article-title>Altered Executive Function in Pre-Mild Cognitive Impairment</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2016</year><volume>54</volume><fpage>933</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.3233/JAD-160052</pub-id><pub-id pub-id-type="pmid">27567814</pub-id>
</element-citation></ref><ref id="B14-geriatrics-10-00065"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verfaillie</surname><given-names>S.C.J.</given-names></name>
<name><surname>Slot</surname><given-names>R.E.</given-names></name>
<name><surname>Tijms</surname><given-names>B.M.</given-names></name>
<name><surname>Bouwman</surname><given-names>F.</given-names></name>
<name><surname>Benedictus</surname><given-names>M.R.</given-names></name>
<name><surname>Overbeek</surname><given-names>J.M.</given-names></name>
<name><surname>Koene</surname><given-names>T.</given-names></name>
<name><surname>Vrenken</surname><given-names>H.</given-names></name>
<name><surname>Scheltens</surname><given-names>P.</given-names></name>
<name><surname>Barkhof</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory</article-title><source>Neurobiol. Aging</source><year>2018</year><volume>61</volume><fpage>238</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2017.09.009</pub-id><pub-id pub-id-type="pmid">29029762</pub-id>
</element-citation></ref><ref id="B15-geriatrics-10-00065"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bae</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>W.</given-names></name>
<name><surname>Kim</surname><given-names>B.</given-names></name>
<name><surname>Chang</surname><given-names>S.</given-names></name>
<name><surname>Lee</surname><given-names>D.</given-names></name>
<name><surname>Cho</surname><given-names>M.</given-names></name>
</person-group><article-title>Associations between subjective memory complaints and executive functions in a community sample of elderly without cognitive dysfunction</article-title><source>Alzheimer&#x02019;s Dement.</source><year>2017</year><volume>13</volume><fpage>1183</fpage><pub-id pub-id-type="doi">10.1016/j.jalz.2017.06.1755</pub-id></element-citation></ref><ref id="B16-geriatrics-10-00065"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Viviano</surname><given-names>R.P.</given-names></name>
<name><surname>Hayes</surname><given-names>J.M.</given-names></name>
<name><surname>Pruitt</surname><given-names>P.J.</given-names></name>
<name><surname>Fernandez</surname><given-names>Z.J.</given-names></name>
<name><surname>van Rooden</surname><given-names>S.</given-names></name>
<name><surname>van der Grond</surname><given-names>J.</given-names></name>
<name><surname>Rombouts</surname><given-names>S.</given-names></name>
<name><surname>Damoiseaux</surname><given-names>J.S.</given-names></name>
</person-group><article-title>Aberrant memory system connectivity and working memory performance in subjective cognitive decline</article-title><source>Neuroimage</source><year>2019</year><volume>15</volume><fpage>556</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.10.015</pub-id><pub-id pub-id-type="pmid">30308246</pub-id>
</element-citation></ref><ref id="B17-geriatrics-10-00065"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Valech</surname><given-names>N.</given-names></name>
<name><surname>Tort-Merino</surname><given-names>A.</given-names></name>
<name><surname>Coll-Padr&#x000f3;s</surname><given-names>N.</given-names></name>
<name><surname>Olives</surname><given-names>J.</given-names></name>
<name><surname>Le&#x000f3;n</surname><given-names>M.</given-names></name>
<name><surname>Rami</surname><given-names>L.</given-names></name>
<name><surname>Molinuevo</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer&#x02019;s Disease from Normal Aging</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2018</year><volume>61</volume><fpage>689</fpage><lpage>703</lpage><pub-id pub-id-type="doi">10.3233/JAD-170627</pub-id><pub-id pub-id-type="pmid">29254090</pub-id>
</element-citation></ref><ref id="B18-geriatrics-10-00065"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000e9;rez-Cord&#x000f3;n</surname><given-names>A.</given-names></name>
<name><surname>Mont&#x000e9;-Rubio</surname><given-names>G.</given-names></name>
<name><surname>Sanabria</surname><given-names>A.</given-names></name>
<name><surname>Rodriguez-Gomez</surname><given-names>O.</given-names></name>
<name><surname>Valero</surname><given-names>S.</given-names></name>
<name><surname>Abdelnour</surname><given-names>C.</given-names></name>
<name><surname>Marqui&#x000e9;</surname><given-names>M.</given-names></name>
<name><surname>Espinosa</surname><given-names>A.</given-names></name>
<name><surname>Ortega</surname><given-names>G.</given-names></name>
<name><surname>Hernandez</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: The FACEHBI cohort</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>17721</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-74704-7</pub-id><pub-id pub-id-type="pmid">33082443</pub-id>
</element-citation></ref><ref id="B19-geriatrics-10-00065"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kim</surname><given-names>W.H.</given-names></name>
<name><surname>Kim</surname><given-names>B.S.</given-names></name>
<name><surname>Chang</surname><given-names>S.M.</given-names></name>
<name><surname>Lee</surname><given-names>D.W.</given-names></name>
<name><surname>Bae</surname><given-names>J.N.</given-names></name>
</person-group><article-title>Relationship between subjective memory complaint and executive function in a community sample of South Korean elderly</article-title><source>Psychogeriatrics</source><year>2020</year><volume>20</volume><fpage>850</fpage><lpage>857</lpage><pub-id pub-id-type="doi">10.1111/psyg.12592</pub-id><pub-id pub-id-type="pmid">32808460</pub-id>
</element-citation></ref><ref id="B20-geriatrics-10-00065"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hao</surname><given-names>L.</given-names></name>
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>Z.</given-names></name>
<name><surname>Wei</surname><given-names>Z.</given-names></name>
<name><surname>Gao</surname><given-names>G.</given-names></name>
<name><surname>Jia</surname><given-names>J.</given-names></name>
<name><surname>Xing</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Demographic characteristics and neuropsychological assessments of subjective cognitive decline (SCD) (plus)</article-title><source>Ann. Clin. Transl. Neurol.</source><year>2020</year><volume>7</volume><fpage>1002</fpage><lpage>1012</lpage><pub-id pub-id-type="doi">10.1002/acn3.51068</pub-id><pub-id pub-id-type="pmid">32588989</pub-id>
</element-citation></ref><ref id="B21-geriatrics-10-00065"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lee</surname><given-names>Y.C.</given-names></name>
<name><surname>Kang</surname><given-names>J.M.</given-names></name>
<name><surname>Lee</surname><given-names>H.</given-names></name>
<name><surname>Kim</surname><given-names>K.</given-names></name>
<name><surname>Kim</surname><given-names>S.</given-names></name>
<name><surname>Yu</surname><given-names>T.Y.</given-names></name>
<name><surname>Lee</surname><given-names>E.M.</given-names></name>
<name><surname>Kim</surname><given-names>C.T.</given-names></name>
<name><surname>Kim</surname><given-names>D.K.</given-names></name>
<name><surname>Lewis</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Subjective cognitive decline and subsequent dementia: A nationwide cohort study of 579,710 people aged 66 years in South Korea</article-title><source>Alzheimer&#x02019;s Res. Ther.</source><year>2020</year><volume>12</volume><fpage>52</fpage><pub-id pub-id-type="doi">10.1186/s13195-020-00618-1</pub-id><pub-id pub-id-type="pmid">32375880</pub-id>
</element-citation></ref><ref id="B22-geriatrics-10-00065"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Numbers</surname><given-names>K.</given-names></name>
<name><surname>Lam</surname><given-names>B.C.P.</given-names></name>
<name><surname>Crawford</surname><given-names>J.D.</given-names></name>
<name><surname>Kochan</surname><given-names>N.A.</given-names></name>
<name><surname>Sachdev</surname><given-names>P.S.</given-names></name>
<name><surname>Brodaty</surname><given-names>H.</given-names></name>
</person-group><article-title>Increased reporting of subjective cognitive complaints over time predicts cognitive decline and incident dementia</article-title><source>Int. J. Geriatr. Psychiatry</source><year>2021</year><volume>36</volume><fpage>1739</fpage><lpage>1747</lpage><pub-id pub-id-type="doi">10.1002/gps.5594</pub-id><pub-id pub-id-type="pmid">34216392</pub-id>
</element-citation></ref><ref id="B23-geriatrics-10-00065"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garrido-Chaves</surname><given-names>R.</given-names></name>
<name><surname>Perez</surname><given-names>V.</given-names></name>
<name><surname>Perez-Alarc&#x000f3;n</surname><given-names>M.</given-names></name>
<name><surname>Crespo-Sanmiguel</surname><given-names>I.</given-names></name>
<name><surname>Paiva</surname><given-names>T.O.</given-names></name>
<name><surname>Hidalgo</surname><given-names>V.</given-names></name>
<name><surname>Pulopulos</surname><given-names>M.M.</given-names></name>
<name><surname>Salvador</surname><given-names>A.</given-names></name>
</person-group><article-title>Subjective MemoryComplaints and Decision Making in Young and Older Adults: An Event-Related Potential Study</article-title><source>Front. Aging Neurosci.</source><year>2021</year><volume>13</volume><elocation-id>695275</elocation-id><pub-id pub-id-type="doi">10.3389/fnagi.2021.695275</pub-id><pub-id pub-id-type="pmid">34803649</pub-id>
</element-citation></ref><ref id="B24-geriatrics-10-00065"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oliver</surname><given-names>M.D.</given-names></name>
<name><surname>Morrison</surname><given-names>C.</given-names></name>
<name><surname>Kamal</surname><given-names>F.</given-names></name>
<name><surname>Graham</surname><given-names>J.</given-names></name>
<name><surname>Dadar</surname><given-names>M.</given-names></name>
</person-group><article-title>Subjective cognitive decline is a better marker for future cognitive decline in females than in males</article-title><source>Alzheimer&#x02019;s Res. Ther.</source><year>2022</year><volume>14</volume><fpage>197</fpage><pub-id pub-id-type="doi">10.1186/s13195-022-01138-w</pub-id><pub-id pub-id-type="pmid">36581949</pub-id>
</element-citation></ref><ref id="B25-geriatrics-10-00065"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morrison</surname><given-names>C.</given-names></name>
<name><surname>Dadar</surname><given-names>M.</given-names></name>
<name><surname>Shafiee</surname><given-names>N.</given-names></name>
<name><surname>Villeneuve</surname><given-names>S.</given-names></name>
<name><surname>Louis Collins</surname><given-names>D.</given-names></name>
<collab>Alzheimer&#x02019;s Disease Neuroimaging Initiative</collab>
</person-group><article-title>Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline</article-title><source>Neuroimage Clin.</source><year>2022</year><volume>33</volume><fpage>102923</fpage><pub-id pub-id-type="doi">10.1016/j.nicl.2021.102923</pub-id><pub-id pub-id-type="pmid">34959049</pub-id>
</element-citation></ref><ref id="B26-geriatrics-10-00065"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yates</surname><given-names>J.A.</given-names></name>
<name><surname>Clare</surname><given-names>L.</given-names></name>
<name><surname>Woods</surname><given-names>R.T.</given-names></name>
<collab>MRC CFAS</collab>
</person-group><article-title>Subjective memory complaints, mood and MCI: A follow-up study</article-title><source>Aging Ment. Health</source><year>2017</year><volume>21</volume><fpage>313</fpage><lpage>321</lpage><pub-id pub-id-type="doi">10.1080/13607863.2015.1081150</pub-id><pub-id pub-id-type="pmid">26329364</pub-id>
</element-citation></ref><ref id="B27-geriatrics-10-00065"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Breton</surname><given-names>A.</given-names></name>
<name><surname>Casey</surname><given-names>D.</given-names></name>
<name><surname>Arnaoutoglou</surname><given-names>N.A.</given-names></name>
</person-group><article-title>Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta-analysis of diagnostic accuracy studies</article-title><source>Int. J. Geriatr. Psychiatry</source><year>2019</year><volume>34</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1002/gps.5016</pub-id><pub-id pub-id-type="pmid">30370616</pub-id>
</element-citation></ref><ref id="B28-geriatrics-10-00065"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>T.</given-names></name>
<name><surname>Ferreira</surname><given-names>F.L.</given-names></name>
<name><surname>Cardoso</surname><given-names>S.</given-names></name>
<name><surname>Silva</surname><given-names>D.</given-names></name>
<name><surname>de Mendon&#x000e7;a</surname><given-names>A.</given-names></name>
<name><surname>Guerreiro</surname><given-names>M.</given-names></name>
<name><surname>Madeira</surname><given-names>S.C.</given-names></name>
<collab>Alzheimer&#x02019;s Disease Neuroimaging Initiative</collab>
</person-group><article-title>Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer&#x02019;s disease: A feature selection ensemble combining stability and predictability</article-title><source>BMC Med. Inf. Decis. Mak.</source><year>2018</year><volume>18</volume><elocation-id>137</elocation-id><pub-id pub-id-type="doi">10.1186/s12911-018-0710-y</pub-id><pub-id pub-id-type="pmid">30567554</pub-id>
</element-citation></ref><ref id="B29-geriatrics-10-00065"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pinto</surname><given-names>T.C.C.</given-names></name>
<name><surname>Machado</surname><given-names>L.</given-names></name>
<name><surname>Bulgacov</surname><given-names>T.M.</given-names></name>
<name><surname>Rodrigues-J&#x000fa;nior</surname><given-names>A.L.</given-names></name>
<name><surname>Costa</surname><given-names>M.L.G.</given-names></name>
<name><surname>Ximenes</surname><given-names>R.C.C.</given-names></name>
<name><surname>Sougey</surname><given-names>E.B.</given-names></name>
</person-group><article-title>Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer&#x02019;s Disease (AD) in the elderly?</article-title><source>Int. Psychogeriatr.</source><year>2019</year><volume>31</volume><fpage>491</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1017/S1041610218001370</pub-id><pub-id pub-id-type="pmid">30426911</pub-id>
</element-citation></ref><ref id="B30-geriatrics-10-00065"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jongsiriyanyong</surname><given-names>S.</given-names></name>
<name><surname>Limpawattana</surname><given-names>P.</given-names></name>
</person-group><article-title>Mild Cognitive Impairment in Clinical Practice: A Review Article</article-title><source>Am. J. Alzheimer&#x02019;s Dis. Other Demen</source><year>2018</year><volume>33</volume><fpage>500</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1177/1533317518791401</pub-id><pub-id pub-id-type="pmid">30068225</pub-id>
</element-citation></ref><ref id="B31-geriatrics-10-00065"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kueper</surname><given-names>J.K.</given-names></name>
<name><surname>Speechley</surname><given-names>M.</given-names></name>
<name><surname>Montero-Odasso</surname><given-names>M.</given-names></name>
</person-group><article-title>The Alzheimer&#x02019;s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2018</year><volume>63</volume><fpage>423</fpage><lpage>444</lpage><pub-id pub-id-type="doi">10.3233/JAD-170991</pub-id><pub-id pub-id-type="pmid">29660938</pub-id>
</element-citation></ref><ref id="B32-geriatrics-10-00065"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oghabon</surname><given-names>E.K.</given-names></name>
<name><surname>Gim&#x000e9;nez-Llort</surname><given-names>L.</given-names></name>
</person-group><article-title>Short height and poor education increase the risk of dementia in Nigerian type 2 diabetic women</article-title><source>Alzheimer&#x02019;s Dement.</source><year>2019</year><volume>11</volume><fpage>493</fpage><lpage>499</lpage><pub-id pub-id-type="doi">10.1016/j.dadm.2019.05.006</pub-id></element-citation></ref><ref id="B33-geriatrics-10-00065"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhuang</surname><given-names>L.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Gao</surname><given-names>J.</given-names></name>
</person-group><article-title>Cognitive assessment tools for mild cognitive impairment screening</article-title><source>J. Neurol.</source><year>2021</year><volume>268</volume><fpage>1615</fpage><lpage>1622</lpage><pub-id pub-id-type="doi">10.1007/s00415-019-09506-7</pub-id><pub-id pub-id-type="pmid">31414193</pub-id>
</element-citation></ref><ref id="B34-geriatrics-10-00065"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gainotti</surname><given-names>G.</given-names></name>
<name><surname>Quaranta</surname><given-names>D.</given-names></name>
<name><surname>Vita</surname><given-names>M.G.</given-names></name>
<name><surname>Marra</surname><given-names>C.</given-names></name>
</person-group><article-title>Neuropsychological predictors of conversion from mild cognitive impairment to Alzheimer&#x02019;s disease</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2014</year><volume>38</volume><fpage>481</fpage><lpage>495</lpage><pub-id pub-id-type="doi">10.3233/JAD-130881</pub-id><pub-id pub-id-type="pmid">24002185</pub-id>
</element-citation></ref><ref id="B35-geriatrics-10-00065"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>M.L.</given-names></name>
<name><surname>de Vasconcelos</surname><given-names>T.H.F.</given-names></name>
<name><surname>de Oliveira</surname><given-names>A.A.R.</given-names></name>
<name><surname>Campagnolo</surname><given-names>S.B.</given-names></name>
<name><surname>Figueiredo</surname><given-names>S.O.</given-names></name>
<name><surname>Guimar&#x000e3;es</surname><given-names>A.F.B.C.</given-names></name>
<name><surname>Barbosa</surname><given-names>M.T.</given-names></name>
<name><surname>de Miranda</surname><given-names>L.F.J.R.</given-names></name>
<name><surname>Caramelli</surname><given-names>P.</given-names></name>
<name><surname>de Souza</surname><given-names>L.C.</given-names></name>
</person-group><article-title>Memory complaints at primary care in a middle-income country: Clinical and neuropsychological characterization</article-title><source>Dement. Neuropsychol.</source><year>2021</year><volume>15</volume><fpage>88</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1590/1980-57642021dn15-010009</pub-id><pub-id pub-id-type="pmid">33907601</pub-id>
</element-citation></ref><ref id="B36-geriatrics-10-00065"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Folia</surname><given-names>V.</given-names></name>
<name><surname>Liampas</surname><given-names>I.</given-names></name>
<name><surname>Siokas</surname><given-names>V.</given-names></name>
<name><surname>Silva</surname><given-names>S.</given-names></name>
<name><surname>Ntanasi</surname><given-names>E.</given-names></name>
<name><surname>Yannakoulia</surname><given-names>M.</given-names></name>
<name><surname>Sakka</surname><given-names>P.</given-names></name>
<name><surname>Hadjigeorgiou</surname><given-names>G.</given-names></name>
<name><surname>Scarmeas</surname><given-names>N.</given-names></name>
<name><surname>Dardiotis</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Language performance as a prognostic factor for developing Alzheimer&#x02019;s clinical syndrome and mild cognitive impairment: Results from the population-based HELIAD cohort</article-title><source>J. Int. Neuropsychol. Soc.</source><year>2023</year><volume>29</volume><fpage>450</fpage><lpage>458</lpage><pub-id pub-id-type="doi">10.1017/S1355617722000376</pub-id><pub-id pub-id-type="pmid">36268843</pub-id>
</element-citation></ref><ref id="B37-geriatrics-10-00065"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Macoir</surname><given-names>J.</given-names></name>
<name><surname>Tremblay</surname><given-names>P.</given-names></name>
<name><surname>Hudon</surname><given-names>C.</given-names></name>
</person-group><article-title>The Use of Executive Fluency Tasks to Detect Cognitive Impairment in Individuals with Subjective Cognitive Decline</article-title><source>Behav. Sci.</source><year>2022</year><volume>12</volume><elocation-id>491</elocation-id><pub-id pub-id-type="doi">10.3390/bs12120491</pub-id><pub-id pub-id-type="pmid">36546974</pub-id>
</element-citation></ref><ref id="B38-geriatrics-10-00065"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Allain</surname><given-names>P.</given-names></name>
<name><surname>Etcharry-Bouyx</surname><given-names>F.</given-names></name>
<name><surname>Verny</surname><given-names>C.</given-names></name>
</person-group><article-title>Executive functions in clinical and preclinical Alzheimer&#x02019;s disease</article-title><source>Rev. Neurol.</source><year>2013</year><volume>169</volume><fpage>695</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/j.neurol.2013.07.020</pub-id><pub-id pub-id-type="pmid">24011643</pub-id>
</element-citation></ref><ref id="B39-geriatrics-10-00065"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Webster-Cordero</surname><given-names>F.</given-names></name>
<name><surname>Gim&#x000e9;nez-Llort</surname><given-names>L.</given-names></name>
</person-group><article-title>The Challenge of Subjective Cognitive Complaints and Executive Functions in Middle-Aged Adults as a Preclinical Stage of Dementia: A Systematic Review</article-title><source>Geriatrics</source><year>2022</year><volume>7</volume><elocation-id>30</elocation-id><pub-id pub-id-type="doi">10.3390/geriatrics7020030</pub-id><pub-id pub-id-type="pmid">35314602</pub-id>
</element-citation></ref><ref id="B40-geriatrics-10-00065"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Desai</surname><given-names>R.</given-names></name>
<name><surname>Whitfield</surname><given-names>T.</given-names></name>
<name><surname>Said</surname><given-names>G.</given-names></name>
<name><surname>John</surname><given-names>A.</given-names></name>
<name><surname>Saunders</surname><given-names>R.</given-names></name>
<name><surname>Marchant</surname><given-names>N.L.</given-names></name>
<name><surname>Stott</surname><given-names>J.</given-names></name>
<name><surname>Charlesworth</surname><given-names>G.</given-names></name>
</person-group><article-title>Affective symptoms and risk of progression to mild cognitive impairment or dementia in subjective cognitive decline: A systematic review and meta-analysis</article-title><source>Ageing Res. Rev.</source><year>2021</year><volume>71</volume><fpage>101419</fpage><pub-id pub-id-type="doi">10.1016/j.arr.2021.101419</pub-id><pub-id pub-id-type="pmid">34390850</pub-id>
</element-citation></ref><ref id="B41-geriatrics-10-00065"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liew</surname><given-names>T.M.</given-names></name>
</person-group><article-title>Depression, subjective cognitive decline, and the risk of neurocognitive disorders</article-title><source>Alzheimer&#x02019;s Res. Ther.</source><year>2019</year><volume>11</volume><fpage>70</fpage><pub-id pub-id-type="doi">10.1186/s13195-019-0527-7</pub-id><pub-id pub-id-type="pmid">31399132</pub-id>
</element-citation></ref><ref id="B42-geriatrics-10-00065"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Isella</surname><given-names>V.</given-names></name>
<name><surname>Villa</surname><given-names>L.</given-names></name>
<name><surname>Russo</surname><given-names>A.</given-names></name>
<name><surname>Regazzoni</surname><given-names>R.</given-names></name>
<name><surname>Ferrarese</surname><given-names>C.</given-names></name>
<name><surname>Appollonio</surname><given-names>I.M.</given-names></name>
</person-group><article-title>Discriminative and predictive power of an informant report in mild cognitive impairment</article-title><source>J. Neurol. Neurosurg. Psychiatry</source><year>2006</year><volume>77</volume><fpage>166</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2005.069765</pub-id><pub-id pub-id-type="pmid">16421116</pub-id>
</element-citation></ref><ref id="B43-geriatrics-10-00065"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Almeida</surname><given-names>M.L.</given-names></name>
<name><surname>Dalpubel</surname><given-names>D.</given-names></name>
<name><surname>Ribeiro</surname><given-names>E.B.</given-names></name>
<name><surname>de Oliveira</surname><given-names>E.S.B.</given-names></name>
<name><surname>Ansai</surname><given-names>J.H.</given-names></name>
<name><surname>Vale</surname><given-names>F.A.C.</given-names></name>
</person-group><article-title>Subjective cognitive impairment, cognitive disorders and self-perceived health: The importance of the informant</article-title><source>Dement. Neuropsychol.</source><year>2019</year><volume>13</volume><fpage>335</fpage><lpage>342</lpage><pub-id pub-id-type="doi">10.1590/1980-57642018dn13-030011</pub-id><pub-id pub-id-type="pmid">31555407</pub-id>
</element-citation></ref><ref id="B44-geriatrics-10-00065"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farfel</surname><given-names>J.M.</given-names></name>
<name><surname>Barnes</surname><given-names>L.L.</given-names></name>
<name><surname>Capuano</surname><given-names>A.</given-names></name>
<name><surname>Sampaio</surname><given-names>M.C.M.</given-names></name>
<name><surname>Wilson</surname><given-names>R.S.</given-names></name>
<name><surname>Bennett</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Informant-Reported Discrimination, Dementia, and Cognitive Impairment in Older Brazilians</article-title><source>J. Alzheimer&#x02019;s Dis.</source><year>2021</year><volume>84</volume><fpage>973</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.3233/JAD-201436</pub-id><pub-id pub-id-type="pmid">33935076</pub-id>
</element-citation></ref><ref id="B45-geriatrics-10-00065"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caselli</surname><given-names>R.J.</given-names></name>
<name><surname>Langlais</surname><given-names>B.T.</given-names></name>
<name><surname>Dueck</surname><given-names>A.C.</given-names></name>
<name><surname>Henslin</surname><given-names>B.R.</given-names></name>
<name><surname>Johnson</surname><given-names>T.A.</given-names></name>
<name><surname>Woodruff</surname><given-names>B.K.</given-names></name>
<name><surname>Hoffman-Snyder</surname><given-names>C.</given-names></name>
<name><surname>Locke</surname><given-names>D.E.C.</given-names></name>
</person-group><article-title>Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment</article-title><source>J. Am. Geriatr. Soc.</source><year>2018</year><volume>66</volume><fpage>671</fpage><lpage>678</lpage><pub-id pub-id-type="doi">10.1111/jgs.15182</pub-id><pub-id pub-id-type="pmid">29341070</pub-id>
</element-citation></ref><ref id="B46-geriatrics-10-00065"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Terracciano</surname><given-names>A.</given-names></name>
<name><surname>Luchetti</surname><given-names>M.</given-names></name>
<name><surname>Stephan</surname><given-names>Y.</given-names></name>
<name><surname>L&#x000f6;ckenhoff</surname><given-names>C.E.</given-names></name>
<name><surname>Ledermann</surname><given-names>T.</given-names></name>
<name><surname>Sutin</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Changes in Personality Before and During Cognitive Impairment</article-title><source>J. Am. Med. Dir. Assoc.</source><year>2023</year><volume>24</volume><fpage>1465</fpage><lpage>1470.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jamda.2023.05.011</pub-id><pub-id pub-id-type="pmid">37330217</pub-id>
</element-citation></ref><ref id="B47-geriatrics-10-00065"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Franzen</surname><given-names>S.</given-names></name>
<name><surname>van den Berg</surname><given-names>E.</given-names></name>
<name><surname>Goudsmit</surname><given-names>M.</given-names></name>
<name><surname>Jurgens</surname><given-names>C.K.</given-names></name>
<name><surname>van de Wiel</surname><given-names>L.</given-names></name>
<name><surname>Kalkisim</surname><given-names>Y.</given-names></name>
<name><surname>Uysal-Bozkir</surname><given-names>&#x000d6;.</given-names></name>
<name><surname>Ayhan</surname><given-names>Y.</given-names></name>
<name><surname>Nielsen</surname><given-names>T.R.</given-names></name>
<name><surname>Papma</surname><given-names>J.M.</given-names></name>
</person-group><article-title>A Systematic Review of Neuropsychological Tests for the Assessment of Dementia in Non-Western, Low-Educated or Illiterate Populations</article-title><source>J. Int. Neuropsychol. Soc.</source><year>2020</year><volume>26</volume><fpage>331</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1017/S1355617719000894</pub-id><pub-id pub-id-type="pmid">31511111</pub-id>
</element-citation></ref><ref id="B48-geriatrics-10-00065"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>T.R.</given-names></name>
</person-group><article-title>Cognitive Assessment in Culturally, Linguistically, and Educationally Diverse Older Populations in Europe</article-title><source>Am. J. Alzheimer&#x02019;s Dis. Other Demen</source><year>2022</year><volume>37</volume><fpage>15333175221117006</fpage><pub-id pub-id-type="doi">10.1177/15333175221117006</pub-id><pub-id pub-id-type="pmid">36325840</pub-id>
</element-citation></ref><ref id="B49-geriatrics-10-00065"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chun</surname><given-names>C.T.</given-names></name>
<name><surname>Seward</surname><given-names>K.</given-names></name>
<name><surname>Patterson</surname><given-names>A.</given-names></name>
<name><surname>Melton</surname><given-names>A.</given-names></name>
<name><surname>MacDonald-Wicks</surname><given-names>L.</given-names></name>
</person-group><article-title>Evaluation of Available Cognitive Tools Used to Measure Mild Cognitive Decline: A Scoping Review</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><elocation-id>3974</elocation-id><pub-id pub-id-type="doi">10.3390/nu13113974</pub-id><pub-id pub-id-type="pmid">34836228</pub-id>
</element-citation></ref><ref id="B50-geriatrics-10-00065"><label>50.</label><element-citation publication-type="confproc"><person-group person-group-type="author">
<name><surname>Vostr&#x000fd;</surname><given-names>M.</given-names></name>
<name><surname>Zilcher</surname><given-names>L.</given-names></name>
</person-group><article-title>The use of rehabilitation therapy with the participation of people with different types of neurological disease from the perspective of helping professions</article-title><source>Proceedings of the 12th annual International Conference of Education, Research and Innovation</source><conf-loc>Seville, Spain</conf-loc><conf-date>11&#x02013;13 November 2019</conf-date><fpage>104</fpage><lpage>109</lpage></element-citation></ref></ref-list></back><floats-group><fig position="float" id="geriatrics-10-00065-f001"><label>Figure 1</label><caption><p>Flow chart of the systematic review neuropsychological evaluation of SCC (2009&#x02013;2024).</p></caption><graphic xlink:href="geriatrics-10-00065-g001" position="float"/></fig><fig position="float" id="geriatrics-10-00065-f002"><label>Figure 2</label><caption><p>Neuropsychological Domains Assessed in Subjective Cognitive Complaints. Myriad neuropsychological domains assessed in people with subjective cognitive complaints. The number of works addressing the domains is shown in percentages. Domains assessed according to the respective authors: Screening scales. Tests for depression and anxiety, intelligence, praxis, language, visual perception, visuospatial perception, executive function, and memory. Self and informant report.</p></caption><graphic xlink:href="geriatrics-10-00065-g002" position="float"/></fig><table-wrap position="float" id="geriatrics-10-00065-t001"><object-id pub-id-type="pii">geriatrics-10-00065-t001_Table 1</object-id><label>Table 1</label><caption><p>Studies about neuropsychological domains and assessment tools in subjective cognitive complaints.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Authors [Reference] Country</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample <break/>Subjects&#x02019; Diagnosis <break/>(Gender Ratio) [Mean Age] {Mean Years of Education}</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Domains Assessed</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tests Used</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">van Harten et al. [<xref rid="B11-geriatrics-10-00065" ref-type="bibr">11</xref>]<break/>The Netherlands</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">132 participants with SCC<break/>(56 W:76 M) [61.4] {6}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"> MMSE <break/>-<break/>-<break/>-<break/>Semantic fluency<break/>-<break/>-<break/>TMT A-B, DST<break/>VAT, RAVLT<break/>- </td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Toledo et al. [<xref rid="B12-geriatrics-10-00065" ref-type="bibr">12</xref>]<break/>USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">522 participants <break/>(253 W:269 M):<break/>307 CN subjects <break/>(138 W:169 M) [73.9] {-}<break/>71 subjects SCC<break/>(25 W:46 M) [71.6] {-}<break/>51 subjects executive SCI<break/>(21 W:30 M) [77.3] {-}<break/>66 subjects memory SCI <break/>(49 W:17 M) [75] {-}<break/>27 subjects multi-domain SCI <break/>(20 W:7 M) [78] {-}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE, ADAS<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Seo et al. [<xref rid="B13-geriatrics-10-00065" ref-type="bibr">13</xref>]<break/>Korea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">265 participants<break/>(178 W:79 M):<break/>188 CN subjects <break/>(120 W:60 M) [71.94] {9.69}<break/>77 subjects pre-DCL<break/>(58 W:19 M) [72.64] {9.64} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE, SNSB<break/>GDS<break/>-<break/>RCFT<break/>CPFT, K-BNT<break/>-<break/>RCFT<break/>TMT A-B, DST, Stroop test, <break/>SVLT<break/>SMCQ (informant report)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Verfaillie et al. [<xref rid="B14-geriatrics-10-00065" ref-type="bibr">14</xref>]<break/>The Netherlands</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">233 participants SCD <break/>(107 W: 125 M) [62.82] {5.32} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE<break/>GDS<break/>-<break/>-<break/>Semantic fluency<break/>-<break/>-<break/>TMT A-B, DST, Stroop test<break/>RAVLT, VAT<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bae et al. [<xref rid="B15-geriatrics-10-00065" ref-type="bibr">15</xref>]<break/>South Korea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1442 participants<break/>(-) [-] {-}:<break/>1088 HC subjects (-) [-] {-} <break/>354 SCC (-) [-] {-}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>K-DRS (Inhibition/Perseveration)<break/>-<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viviano et al. [<xref rid="B16-geriatrics-10-00065" ref-type="bibr">16</xref>]<break/>USA, The Netherlands</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83 participants (51 W:32 M):<break/>35 adults with SCI<break/>(22 W:13 M) [68.5] {-} <break/>48 adults without SCI <break/>(29 W:19 M) [67.08] {-} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE, BFI<break/>GDS, BDI<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>WMS<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Valech et al. [<xref rid="B17-geriatrics-10-00065" ref-type="bibr">17</xref>]<break/>Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68 normal subjects <break/>(46 W:22 M):<break/>52 HC<break/>(33 W:19 M) [63.87] {11.96} <break/>16 pre-AD <break/>(13 W and 3 M) [66.5] {9.56} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE<break/>HADS<break/>-<break/>-<break/>BNT, BDAE, Semantic fluency<break/>VOSP<break/>-<break/>TMT A, Stroop test<break/>MAT, FCSRT-IR<break/>SCD-Q</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P&#x000e9;rez et al. [<xref rid="B18-geriatrics-10-00065" ref-type="bibr">18</xref>]<break/>Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">195 participants SCD <break/>(121 W:74 M) [65.71] {14.94}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-<break/>-<break/>WAIS<break/>-<break/>Semantic fluency, Phonological fluency<break/>-<break/>-<break/>TMT A-B, RSCS-BADS, AI-SKT<break/>-<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Kim et al. [<xref rid="B19-geriatrics-10-00065" ref-type="bibr">19</xref>]<break/>Korea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1442 participants<break/>(886 W:556 M) [&#x02265;65 years]:<break/>1088 HC subjects<break/>(642 W:446 M) {5.66}<break/>354 SCC subjects<break/>(244 W:110 M) {3.33}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE-KC<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>K-DRS (Inhibition/Perseveration)<break/>-<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hao et al. [<xref rid="B20-geriatrics-10-00065" ref-type="bibr">20</xref>]<break/>China</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">615 subjects SCD <italic toggle="yes">plus</italic>
<break/>(378 W:228 M) [-] {-} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MoCA<break/>-<break/>-<break/>CDT<break/>Semantic fluency<break/>-<break/>-<break/>TMT B<break/>AVLT-H<break/>SCD-Q</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lee et al. [<xref rid="B21-geriatrics-10-00065" ref-type="bibr">21</xref>]<break/>Korea</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">579.710 subjects <break/>(313.399 W:266.311 M) [66] {11.6}:<break/>357.654 subjects Non-SCD<break/>222.056 subjects SCD </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>(KDSQ-P)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Numbers et al. [<xref rid="B22-geriatrics-10-00065" ref-type="bibr">22</xref>]<break/>Australia </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">873 subjects SCD <break/>(480 W:392 M) [78.65] {-}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-<break/>-<break/>-<break/>-<break/>BNT, Semantic fluency, Phonological fluency<break/>-<break/>Block Design <break/>Digit Symbol Coding, TMT A-B,<break/>WMS, RAVLT, Benton Visual Test<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Garrido et al. [<xref rid="B23-geriatrics-10-00065" ref-type="bibr">23</xref>]<break/>Spain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">136 participants (67 W:59 M):<break/>28 young adults with SCC <break/>(17 W:11 M) [21] {-} <break/>37 young adults without SCC <break/>(16 W:11 M) [23] {-} <break/>32 older adults with SCC <break/>(18 W:14 M) [63] {-} <break/>39 older adults without SCC <break/>(16 W:23 M) [65] {-} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE<break/>-<break/>-<break/>RCFT<break/>Semantic fluency, <break/>Phonological fluency<break/>-<break/>-<break/>TMT A-B, Stroop test, DST, IGT<break/>FCSRT<break/>MFE-30</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Oliver et al. [<xref rid="B24-geriatrics-10-00065" ref-type="bibr">24</xref>]<break/>USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3019 healthy older adults<break/>831 with SCD<break/>(635 W:196 M)<break/>2188 without SCD <break/>(1660 W:528 M) [73.6] {14.74} </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><break/>-<break/>-<break/>-<break/>-<break/>BNT<break/>NC<break/>PM, Line Orientation<break/>DST, SDMT, Stroop test<break/>WMSR, EBS, WLMR<break/>-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Morrison et al. [<xref rid="B25-geriatrics-10-00065" ref-type="bibr">25</xref>]<break/>Canada</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">273 participants:<break/>97 with SCD <break/>(36 W:61 M)<break/>176 without SCD <break/>(90 W:86 M) <break/>[72.97] {16.66}</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening scales <break/>Depression/anxiety scales<break/>Intelligence <break/>Praxis<break/>Language <break/>Visual perception <break/>Visuospatial <break/>Executive function <break/>Memory<break/>Self/Informant report</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ADAS-13, MMSE, MoCA<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-<break/>-</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: W: women. M: men. SCC: subjective cognitive complaints. SCD: subjective cognitive decline. SCI: subtle cognitive impairment. HC: Healthy control. MMSE: Mini-mental Scale Examination. ADAS: Alzheimer&#x02019;s Disease Assessment Scale. MoCA: Montreal cognitive assessment. WAIS: Wechsler Adult Intelligence Scale. RCFT: Rey&#x02013;Osterrieth complex figure test. BNT: Boston Naming Test. K-BNT: Korean version of the Boston Naming Test. CDT: Clock Drawing Test. TMT (A-B): Trail Making Test. RAVLT: Rey Auditory Verbal Learning Test. DST: Digit span test. VAT: Visual Association Test. SNSB: Seoul Neuropsychological Screening Battery. GDS: Geriatric Depression Scale. CPFT: Categorical and phonemic fluency tests. SVLT: Seoul Verbal Learning Test. SMCQ: Subjective Memory Complaints Questionnaire. K-DRS: Subscale of the Korean version of Matts Dementia Rating Scale. BFI: Big Five Inventory. BDI: Beck Depression Inventory. WMS: Weschler Memory Scale. HADS: Hospital Anxiety and Depression Scale. BDAE: Boston Diagnostic Aphasia Examination-III Edition. VOSP: Visual Object and Space Perception Battery. MAT: Memory Alteration Test. FCSRT-IR: Free and Cued Selective Reminding Test. SCD-Q: Subjective Cognitive Decline Questionnaire. RSCS-BADS: Rule Shift Cards subtest. AI-SKT: Automatic inhibition subtest. MMSE-KC: Mini-mental Mental State Examination Korean version. K-DRS: Korean rating scale. AVLT-H: Auditory Verbal Learning Test Hua Shan. IGT: Iowa Gambling Task. FCSRT: Free and Cued Selective Reminding Test. MFE-30: Memory Failures of Everyday Questionnaire. NC: Number Comparison. PM: Progressive Matrices. SDMT: Symbol Digital Modalities Test. WMSR: Wechsler Memory Scale-Revised. EBS: East Boston Story, WLMR: Word List Memory Recall and Recognition. KDSQ-P: Pre-screening Korean Dementia Screening Questionnaire.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="geriatrics-10-00065-t002"><object-id pub-id-type="pii">geriatrics-10-00065-t002_Table 2</object-id><label>Table 2</label><caption><p>Main tools used to assess cognitive domains in people with subjective cognitive complaints.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Domains</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Tool</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Screening</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MMSE</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Executive function</td><td align="center" valign="middle" rowspan="1" colspan="1">TMT A-B</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">62</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Stroop test</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DST</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Language</td><td align="center" valign="middle" rowspan="1" colspan="1">Semantic and Phonological fluency test</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BNT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">31</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Memory</td><td align="center" valign="middle" rowspan="1" colspan="1">RAVLT</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">31</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WMS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Depression and Anxiety</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GDS</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: MMSE: Mini-mental Scale Examination. TMT (A-B): Trail Making Test. DST: Digit span test. BNT: Boston Naming Test. RAVLT: Rey Auditory Verbal Learning Test. WMS: Weschler Memory Scale. GDS: Geriatric Depression Scale.</p></fn></table-wrap-foot></table-wrap></floats-group></article>